UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 2, 2026
Sale
Calculated transaction value
$1.05M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 30, 2026
Public filing date
Nov 2, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$598.72
Oct 30, 2026
First close after public filing
$601.32
Nov 3, 2026
Return after filing · so far
-6.54%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,742 shares @ $600.96
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000176
Filing cohort
Transactions in this filing
Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$6.82M
Buys / sales
0 / 13
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Oct 30, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $70.79K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $234.56K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $1.21M |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $48.55K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $348.01K |
| United Therapeutics Corp UTHR | Exercise | Oct 30, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $894.66K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $720.3K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $24.21K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $24.32K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $529.47K |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $433.89K |
| United Therapeutics Corp UTHR Current | Sale | Oct 30, 2026 | $1.05M |
| United Therapeutics Corp UTHR | Sale | Oct 30, 2026 | $110.51K |